Department of Chemistry, Stanford University, Stanford, CA 94305.
Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA 94305.
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E5859-E5866. doi: 10.1073/pnas.1805358115. Epub 2018 Jun 11.
We report a strategy for generating a combinatorial library of oligonucleotide transporters with varied lipid domains and their use in the efficient transfection of lymphocytes with mRNA in vitro and in vivo. This library is based on amphiphilic charge-altering releasable transporters (CARTs) that contain a lipophilic block functionalized with various side-chain lipids and a polycationic α-amino ester mRNA-binding block that undergoes rearrangement to neutral small molecules, resulting in mRNA release. We show that certain binary mixtures of these lipid-varied CARTs provide up to a ninefold enhancement in mRNA translation in lymphocytes in vitro relative to either a single-lipid CART component alone or the commercial reagent Lipofectamine 2000, corresponding to a striking increase in percent transfection from 9-12% to 80%. Informed by the results with binary mixtures, we further show that CARTs consisting of optimized ratios of the two lead lipids incorporated into a single hybrid-lipid transporter molecule maintain the same delivery efficacy as the noncovalent mixture of two CARTs. The lead lipid CART mixtures and hybrid-lipid CARTs show enhanced lymphocyte transfection in primary T cells and in vivo in mice. This combinatorial approach for rapidly screening mRNA delivery vectors has provided lipid-varied CART mixtures and hybrid-lipid CARTs that exhibit significant improvement in mRNA delivery to lymphocytes, a finding of potentially broad value in research and clinical applications.
我们报告了一种生成具有不同脂质结构域的寡核苷酸转运体组合文库的策略,并将其用于体外和体内高效转染淋巴细胞的 mRNA。该文库基于两亲电荷可释放转运体(CART),其包含一个亲脂性嵌段,该嵌段用各种侧链脂质功能化,并带有聚阳离子α-氨基酸酯 mRNA 结合嵌段,该嵌段会重新排列为中性小分子,从而释放 mRNA。我们表明,与单一脂质 CART 成分或商业试剂 Lipofectamine 2000 相比,这些脂质多样化 CART 的某些二元混合物在体外淋巴细胞中可将 mRNA 翻译提高多达 9 倍,相对于单个脂质 CART 成分或商业试剂 Lipofectamine 2000 而言,这对应于转染效率从 9-12%显著提高到 80%。根据二元混合物的结果,我们进一步表明,由两种先导脂质以优化比例组成的 CART 整合到单个混合脂质转运体分子中,保持与两种 CART 的非共价混合物相同的递药功效。先导脂质 CART 混合物和混合脂质 CART 在原代 T 细胞和小鼠体内显示出增强的淋巴细胞转染作用。这种用于快速筛选 mRNA 递送载体的组合方法提供了脂质多样化的 CART 混合物和混合脂质 CART,它们在向淋巴细胞递送 mRNA 方面表现出显著改善,这一发现可能在研究和临床应用中具有广泛的价值。